Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors
Solventum Corporation (SOLV)
Company Research
Source: GlobeNewswire
BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, today announced the appointment of Elizabeth Mily to its Board of Directors as Independent Director. A highly respected healthcare and financial industry veteran with more than 30 years of experience, Mily brings extensive expertise in corporate strategy, business development and investment leadership to Ampersand as it advances its Address, Navigate, Determine (AND)™ Platform to develop programmed biologics. “We are thrilled to welcome Elizabeth to Ampersand’s Board as we leverage our AND Platform to advance programmed biologi
Read more
Impact Snapshot
Event Time:
SOLV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SOLV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SOLV alerts
High impacting Solventum Corporation news events
Weekly update
A roundup of the hottest topics
SOLV
News
- Solventum Launches Attest™ eBowie-Dick Test System Revolutionizing Sterilization AssurancePR Newswire
- Solventum Co. (NYSE: SOLV) had its price target raised by analysts at Morgan Stanley from $73.00 to $80.00. They now have an "equal weight" rating on the stock.MarketBeat
- Solventum Co. (NYSE: SOLV) had its price target raised by analysts at Mizuho from $70.00 to $82.00. They now have a "neutral" rating on the stock.MarketBeat
- Solventum Co. (NYSE: SOLV) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $63.00 to $71.00. They now have a "sell" rating on the stock.MarketBeat
- Solventum Co. (NYSE: SOLV) had its price target raised by analysts at Wells Fargo & Company from $73.00 to $75.00. They now have an "equal weight" rating on the stock.MarketBeat
SOLV
Earnings
- 2/27/25 - Beat
SOLV
Sec Filings
- 2/28/25 - Form IRANNOTICE
- 2/28/25 - Form 10-K
- 2/27/25 - Form 8-K
- SOLV's page on the SEC website